Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.

Hutchinson JM, Mesa KA, Alexander DL, Yu B, O'Rourke SM, Limoli KL, Wrin T, Deeks SG, Berman PW.

Front Immunol. 2019 May 15;10:1021. doi: 10.3389/fimmu.2019.01021. eCollection 2019.

2.

Underrepresented Minority Physician Assistant Faculty Mentorship: It Takes a Village.

Alexander DL 3rd, Sturges D.

J Physician Assist Educ. 2019 Jun;30(2):122-124. doi: 10.1097/JPA.0000000000000253. No abstract available.

PMID:
31124811
3.

Underrepresented Minority Physician Assistant Faculty Mentorship: It Takes a Village.

Alexander DL 3rd, Sturges D.

J Physician Assist Educ. 2019 Apr 19. doi: 10.1097/JPA.0000000000000253. [Epub ahead of print] No abstract available.

PMID:
31045863
4.

Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.

Mesa KA, Yu B, Wrin T, Petropoulos CJ, Pogson GH, Alexander DL, Perez G, O'Rourke SM, Sinangil F, Robinson J, Conant MA, Berman PW.

PLoS One. 2019 Apr 10;14(4):e0213409. doi: 10.1371/journal.pone.0213409. eCollection 2019.

5.

Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins.

O'Rourke SM, Yu B, Morales JF, Didinger CM, Alexander DL, Vollmers C, Berman PW.

J Immunol Methods. 2019 Feb;465:31-38. doi: 10.1016/j.jim.2018.11.015. Epub 2018 Nov 28.

PMID:
30502324
6.

CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.

Byrne G, O'Rourke SM, Alexander DL, Yu B, Doran RC, Wright M, Chen Q, Azadi P, Berman PW.

PLoS Biol. 2018 Aug 29;16(8):e2005817. doi: 10.1371/journal.pbio.2005817. eCollection 2018 Aug.

7.

Genetic control of ColE1 plasmid stability that is independent of plasmid copy number regulation.

Standley MS, Million-Weaver S, Alexander DL, Hu S, Camps M.

Curr Genet. 2019 Feb;65(1):179-192. doi: 10.1007/s00294-018-0858-0. Epub 2018 Jun 16.

8.

Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.

Doran RC, Tatsuno GP, O'Rourke SM, Yu B, Alexander DL, Mesa KA, Berman PW.

PLoS One. 2018 Apr 24;13(4):e0196370. doi: 10.1371/journal.pone.0196370. eCollection 2018.

9.

Cyp1b1-mediated suppression of lymphoid progenitors in bone marrow by polycyclic aromatic hydrocarbons coordinately impacts spleen and thymus: a selective role for the Ah Receptor.

Larsen MC, N'Jai AU, Alexander DL, Rondelli CM, Forsberg EC, Czuprynski CJ, Jefcoate CR.

Pharmacol Res Perspect. 2016 Jul 29;4(4):e00245. doi: 10.1002/prp2.245. eCollection 2016 Aug.

10.

Structure of a Human Astrovirus Capsid-Antibody Complex and Mechanistic Insights into Virus Neutralization.

Bogdanoff WA, Campos J, Perez EI, Yin L, Alexander DL, DuBois RM.

J Virol. 2017 Jan 3;91(2). pii: e01859-16. doi: 10.1128/JVI.01859-16. Print 2017 Jan 15.

11.

Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody.

Morales JF, Yu B, Perez G, Mesa KA, Alexander DL, Berman PW.

Mol Immunol. 2016 Sep;77:14-25. doi: 10.1016/j.molimm.2016.07.003. Epub 2016 Jul 21.

PMID:
27449907
12.

Changes in pelvic organ prolapse mesh mechanical properties following implantation in rats.

Ulrich D, Edwards SL, Alexander DLJ, Rosamilia A, Werkmeister JA, Gargett CE, Letouzey V.

Am J Obstet Gynecol. 2016 Feb;214(2):260.e1-260.e8. doi: 10.1016/j.ajog.2015.08.071. Epub 2015 Sep 5.

PMID:
26348376
13.

Beware of R(2): Simple, Unambiguous Assessment of the Prediction Accuracy of QSAR and QSPR Models.

Alexander DL, Tropsha A, Winkler DA.

J Chem Inf Model. 2015 Jul 27;55(7):1316-22. doi: 10.1021/acs.jcim.5b00206. Epub 2015 Jul 9.

14.

Random mutagenesis by error-prone pol plasmid replication in Escherichia coli.

Alexander DL, Lilly J, Hernandez J, Romsdahl J, Troll CJ, Camps M.

Methods Mol Biol. 2014;1179:31-44. doi: 10.1007/978-1-4939-1053-3_3.

15.

Quantifying plasmid copy number to investigate plasmid dosage effects associated with directed protein evolution.

Million-Weaver S, Alexander DL, Allen JM, Camps M.

Methods Mol Biol. 2012;834:33-48. doi: 10.1007/978-1-61779-483-4_3.

16.

The Arabidopsis Information Resource (TAIR): improved gene annotation and new tools.

Lamesch P, Berardini TZ, Li D, Swarbreck D, Wilks C, Sasidharan R, Muller R, Dreher K, Alexander DL, Garcia-Hernandez M, Karthikeyan AS, Lee CH, Nelson WD, Ploetz L, Singh S, Wensel A, Huala E.

Nucleic Acids Res. 2012 Jan;40(Database issue):D1202-10. doi: 10.1093/nar/gkr1090. Epub 2011 Dec 2.

17.

Roles of DNA polymerase I in leading and lagging-strand replication defined by a high-resolution mutation footprint of ColE1 plasmid replication.

Allen JM, Simcha DM, Ericson NG, Alexander DL, Marquette JT, Van Biber BP, Troll CJ, Karchin R, Bielas JH, Loeb LA, Camps M.

Nucleic Acids Res. 2011 Sep 1;39(16):7020-33. doi: 10.1093/nar/gkr157. Epub 2011 May 26.

18.

Modeling tissue growth within nonwoven scaffolds pores.

Edwards SL, Church JS, Alexander DL, Russell SJ, Ingham E, Ramshaw JA, Werkmeister JA.

Tissue Eng Part C Methods. 2011 Feb;17(2):123-30. doi: 10.1089/ten.TEC.2010.0182. Epub 2010 Oct 1.

19.
20.

Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles.

Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC.

PLoS Pathog. 2005 Oct;1(2):e17. Epub 2005 Oct 21.

21.

Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii.

Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, Coombs GH, Dunn JD, Ferguson DJ, Sanderson SJ, Wastling JM, Boothroyd JC.

J Biol Chem. 2005 Oct 7;280(40):34245-58. Epub 2005 Jul 7.

22.

CORKSCREW1 defines a novel mechanism of domain specification in the maize shoot.

Alexander DL, Mellor EA, Langdale JA.

Plant Physiol. 2005 Jul;138(3):1396-408. Epub 2005 Jun 24.

23.

Independent recruitment of a conserved developmental mechanism during leaf evolution.

Harrison CJ, Corley SB, Moylan EC, Alexander DL, Scotland RW, Langdale JA.

Nature. 2005 Mar 24;434(7032):509-14.

PMID:
15791256
24.

Developmentally regulated trafficking of the lysosomal membrane protein p67 in Trypanosoma brucei.

Alexander DL, Schwartz KJ, Balber AE, Bangs JD.

J Cell Sci. 2002 Aug 15;115(Pt 16):3253-63.

25.

School employees: the forgotten municipal workers.

Alexander DL.

Occup Med. 2001 Jan-Mar;16(1):65-78. Review.

PMID:
11107225
26.

Metabolism-based polycyclic aromatic acetylene inhibition of CYP1B1 in 10T1/2 cells potentiates aryl hydrocarbon receptor activity.

Alexander DL, Zhang L, Foroozesh M, Alworth WL, Jefcoate CR.

Toxicol Appl Pharmacol. 1999 Dec 1;161(2):123-39.

PMID:
10581206
27.

Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1977-82.

28.

Molecular cloning of p67, a lysosomal membrane glycoprotein from Trypanosoma brucei.

Kelley RJ, Alexander DL, Cowan C, Balber AE, Bangs JD.

Mol Biochem Parasitol. 1999 Jan 5;98(1):17-28.

PMID:
10029306
29.

Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis.

Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR.

J Cell Sci. 1998 Nov;111 ( Pt 22):3311-22.

31.

Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells.

Alexander DL, Eltom SE, Jefcoate CR.

Cancer Res. 1997 Oct 15;57(20):4498-506.

32.

Tobacco industry campaign contributions in Ontario, 1990-95.

Alexander DL, Cohen JE, Ferrence RG, Ashley MJ, Northrup DA, Pollard JS.

Can J Public Health. 1997 Jul-Aug;88(4):230-1. No abstract available.

PMID:
9336090
34.

Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression.

Savas U, Bhattacharyya KK, Christou M, Alexander DL, Jefcoate CR.

J Biol Chem. 1994 May 27;269(21):14905-11.

35.

AIDS and the minority health care worker.

Askari E, Alexander DL.

AAOHN J. 1989 Mar;37(3):109-13.

PMID:
2923629
36.

Chronic lead exposure: a problem for minority workers.

Alexander DL.

AAOHN J. 1989 Mar;37(3):105-8.

PMID:
2923628
37.

Minority workers: educational models for workers, health providers, and planners.

Morris LD, Alexander DL.

AAOHN J. 1989 Mar;37(3):101-4.

PMID:
2923627
38.

The synthesis of benzindene prostacyclin analogs as potential antiulcer agents.

Alexander DL, Lin CH.

Prostaglandins. 1986 Nov;32(5):647-53.

PMID:
3547506
39.

Detection and significance of granulocyte alloimmunization in leukocyte transfusion therapy on neutropenic dogs.

Chow HS, Alexander DL, Epstein RB.

Transfusion. 1983 Jan-Feb;23(1):15-9.

PMID:
6338627

Supplemental Content

Loading ...
Support Center